Association of hypothyroidism with acute COVID-19: a systematic review

References

• Hossain MF, Hasana S, Mamun AA, et al. COVID-19 outbreak: pathogenesis, current therapies, and potentials for future management. Front Pharmacol. 2020 Oct 16;11:563478. PMID: 33178016; PMCID: PMC7596415.
   PubMed Web of Science ®Google Scholar
• Yd G, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients: a review. Allergy. 2021 Feb;76(2):428–455. Epub 2020 Dec 4. PMID: 33185910.
   PubMed Web of Science ®Google Scholar
• Leung TYM, Chan AYL, Chan EW, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020 Dec 9;9(1):2190–2199. PMID: 32940572; PMCID: PMC7586446.
   PubMed Web of Science ®Google Scholar
• Malik J, Zaidi SMJ, Ishaq U, et al. Post-acute COVID-19 syndrome and its prolonged effects: an updated systematic review. medRxiv. 2021;5(9):21256911.
   Google Scholar
• Lisco G, De Tullio A, Jirillo E, et al. Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects. J Endocrinol Invest. 2021 Mar 25:1–14. Epub ahead of print. PMID: 33765288; PMCID: PMC7992516. Doi:https://doi.org/10.1007/s40618-021-01554-z
   Google Scholar
• Chen Q, Allot A, Lu Z. LitCovid: an open database of COVID-19 literature. Nucleic Acids Res. 2021 Jan 8;49(D1):D1534–D1540. PMID: 33166392; PMCID: PMC7778958.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009 Jul 21;339(jul21 1):b2535. PMID: 19622551; PMCID: PMC2714657.
   PubMed Web of Science ®Google Scholar
• Ma LL, Wang YY, Yang ZH, et al. Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: what are they and which is better? Mil Med Res. 2020 Feb 29;7(1):7. PMID: 32111253; PMCID: PMC7049186.
   PubMed Web of Science ®Google Scholar
• Chen M, Zhou W, Xu W. Thyroid Function Analysis in 50 Patients with COVID-19: a Retrospective Study. Thyroid. 2021 Jan;31(1):8–11. Epub 2020 Jul 10. PMID: 32600165.
   PubMed Web of Science ®Google Scholar
• Gao W, Guo W, Guo Y, et al. Thyroid hormone concentrations in severely or critically ill patients with COVID-19. J Endocrinol Invest. 2021 May;44(5):1031–1040. Epub 2020 Nov 2. PMID: 33140379; PMCID: PMC7605732.
   PubMed Web of Science ®Google Scholar
• Khoo B, Tan T, Clarke SA, et al. Thyroid function before, during, and after COVID-19. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e803–e811. PMID: 33180932; PMCID: PMC7823247.
   PubMed Web of Science ®Google Scholar
• Malik J, Malik A, Javaid M, et al. Thyroid function analysis in COVID-19: a retrospective study from a single center. PLoS One. 2021 Mar 30;16(3):e0249421. PMID: 33784355; PMCID: PMC8009384.
   PubMed Web of Science ®Google Scholar
• Lui DTW, Lee CH, Chow WS, et al. Thyroid dysfunction in relation to immune profile, disease status, and outcome in 191 patients with COVID-19. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e926–e935. PMID: 33141191; PMCID: PMC7665541.
   PubMed Web of Science ®Google Scholar
• Lania A, Sandri MT, Cellini M, et al. Thyrotoxicosis in patients with COVID-19: the THYRCOV study. Eur J Endocrinol. 2020 Oct;183(4):381–387. PMID: 32698147.
   PubMed Web of Science ®Google Scholar
• Han T, Kang J, Li G, et al. Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study. Ann Transl Med. 2020 Sep;8(17):1077. PMID: 33145296; PMCID: PMC7576005.
   PubMed Web of Science ®Google Scholar
• Lazartigues E, Qadir MMF, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2’s Reliance on ACE2. Endocrinology. 2020 Sep 1;161(9):bqaa108. PMID: 32652001; PMCID: PMC7454499.
   PubMed Web of Science ®Google Scholar
• Rotondi M, Coperchini F, Ricci G, et al. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021 May;44(5):1085–1090. Epub 2020 Oct 6. PMID: 33025553; PMCID: PMC7538193.
   PubMed Web of Science ®Google Scholar
• Zou R, Wu C, Zhang S, et al. Euthyroid sick syndrome in patients with COVID-19. Front Endocrinol (Lausanne). 2020 Oct 7;11:566439. PMID: 33117282; PMCID: PMC7575767.
   PubMed Web of Science ®Google Scholar
• De Groot LJ. Non-thyroidal illness syndrome is a manifestation of hypothalamic-pituitary dysfunction, and in view of current evidence, should be treated with appropriate replacement therapies. Crit Care Clin. 2006 Jan;22(1):57–86, vi.
   PubMed Web of Science ®Google Scholar
• Ganesan K, Wadud K. Euthyroid sick syndrome. In: StatPearls [Internet]. In: Khurram Wadud, (Ed), Treasure Island (FL): StatPearls Publishing; Nov 2 2020. 2021 Jan–. PMID: 29489255.
   Google Scholar
• McIver B, Gorman CA. Euthyroid sick syndrome: an overview. Thyroid. 1997 Feb 7;7(1):125–132. PMID: 9086580.
   PubMed Web of Science ®Google Scholar
• Contreras-Jurado C, Alonso-Merino E, Saiz-Ladera C, et al. The thyroid hormone receptors inhibit hepatic interleukin-6 signaling during endotoxemia. Sci Rep. 2016 Aug 3;6(1):30990. PMID: 27484112; PMCID: PMC4971531.
   PubMedGoogle Scholar
• Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, et al. REVIEW: treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab. 2005 Aug;90(8):4946–4954. Epub 2005 May 31. PMID: 15928247.
   PubMed Web of Science ®Google Scholar
• Hennessey JV, Espaillat R. Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy. Int J Clin Pract. 2018 Feb;72(2):e13062. Epub 2018 Jan 30. PMID: 29381251; PMCID: PMC5873391.
   Web of Science ®Google Scholar
• Giovanella L, Ruggeri RM, Ovčariček PP, et al. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021 Mar 11:1–8. Epub ahead of print. PMID: 33728279; PMCID: PMC7950424. DOI: https://doi.org/10.1007/s40336-021-00419-y
   Web of Science ®Google Scholar
• Wong CK, Lam CW, Wu AK, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol. 2004 Apr;136(1):95–103. PMID: 15030519; PMCID: PMC1808997.
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell. 2020 Apr 16;181(2):271–280.e8. Epub 2020 Mar 5. PMID: 32142651; PMCID: PMC7102627.
   PubMed Web of Science ®Google Scholar
• Haiming W, Xiaoling X, Yonggang Z, et al. Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. BioRXiv. 2020.
   Google Scholar
• Ruggeri RM, Campennì A, Deandreis D, et al. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol. 2021 Jun 2:1–23. Epub ahead of print. PMID: 34015983; PMCID: PMC8182818. Doi:https://doi.org/10.1080/1744666X.2021.1932467
   Google Scholar